Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Inflammation subverts hippocampal synaptic plasticity in experimental multiple sclerosis.
Mirna-Mediated Macrophage Polarization and its Potential Role in the Regulation of Inflammatory Response.
Positive Effect on Multiple Sclerosis With Treatment of Metabolic Syndrome.
Structural brain abnormalities are related to retinal nerve fiber layer thinning and disease duration in neuromyelitis optica spectrum disorders.
Is the IL-10 Promoter Polymorphism at Position -592 Associated with Immune System-Related Diseases?
A Sphingosine-1-Phosphate Receptor 1-Directed Agonist Reduces Central Nervous System Inflammation in a Plasmacytoid Dendritic Cell-Dependent Manner.
Body fluid biomarkers for multiple sclerosis-the long road to clinical application.
Regulation of cerebrospinal fluid (CSF) flow in neurodegenerative, neurovascular and neuroinflammatory disease.
Onset of clinical and MRI efficacy occurs early after fingolimod treatment initiation in relapsing multiple sclerosis.
Enzymatic deglycosylation converts pathogenic neuromyelitis optica anti-aquaporin-4 immunoglobulin G into therapeutic antibody.
[Therapy adherence to immunomodulator treatment in patients with multiple sclerosis].
New magnetic resonance imaging biomarkers for the diagnosis of multiple sclerosis.
Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.
Neuromyelitis optica IgG stimulates an immunological response in rat astrocyte cultures.
Genetic alterations in quadruple malignancies of a patient with multiple sclerosis: their role in malignancy development and response to therapy.
[Uveitis in multiple sclerosis : Overview and perspectives.]
A Voxel-based Morphometry Study of Grey Matter Volume Changes in Neuromyelitis Optica Patients.
Acute disseminated encephalomyelitis following infectious mononucleosis in a toddler.
Beneficial effects of Rituximab in patients with anti-MAG (myelin-associated glycoprotein) neuropathy: case reports.
Preventive and Therapeutic Effects of Adenanthin on Experimental Autoimmune Encephalomyelitis by Inhibiting NF-κB Signaling.
Short-term evolution of spinal cord damage in multiple sclerosis: a diffusion tensor MRI study.
Contextualized perceptions of movement as a source of expanded insight: People with multiple sclerosis' experience with physiotherapy.
Polymorphisms in the genes coding for iron binding and transporting proteins are associated with disability, severity, and early progression in multiple sclerosis.
Serum levels of LIGHT in MS.
Cerebrospinal fluid aquaporin-4-immunoglobulin G disrupts blood brain barrier.
Pages
« first
‹ previous
…
326
327
328
329
330
331
332
333
334
…
next ›
last »